Peer-Reviewed Scientific Publications
Total Citations >7097 H-index- 21, i10-index 25 (UPDATED April, 2020 https://scholar.google.com/citations?user=wzO8aTMAAAAJ&hl=en
1. Hussain S, Johnson CG, Sciurba J, Cyphert JM, Stober VP, Rice AB, Bulek K, Liu C, Aloor J, Gowdy K, Foster WM, Hollingsworth JW, Fessler MB, Li X, Tighe RM, Garantziotis S. 2019 TLR5 participates in TLR4 signaling and biases towards MyD88 activation in environmental lung injury. Elife. 2020 Jan 28;9. pii: e50458
2. Whitehead GS, Hussain S, Fannin R, Innes CL, Schurman SH, Cook DN, Garantziotis S. 2019 TLR5 activation through flagellin promotes airway inflammation in asthma. Lung. 2020 Apr;198(2):289-298
3. Hussain S. Measurement of Nanoparticle-Induced Mitochondrial Membrane Potential Alterations. Methods Mol Biol. 2019;1894:123-131
4. Mohammadinejad R, Moosavi MA, Tavakol S, Vardard DO, Hosseini V, Rahmati M, Dinig M, Hussain S, Mandegary A, Klionskyj D. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles Autophagy. 2019 15:4-33.
5. Snyder R, Hussain S, Randell SH, Tucker CJ and Garantziotis S. Impaired ciliogenesis in differentiating human bronchial epithelia exposed to multi-walled carbon nanotubes. Part Fibre Toxicol. 2017, 13; 14(1):44.
6. Hilton MG, Taylor AJ, Hussain S, Dandley EC, Griffith EH, Garantziotis S, Parson GN, Bonner JC and Bereman MS. Mapping Differential Cellular Protein Response of Mouse Alveolar Epithelial Cells to Multi-Walled Carbon Nanotubes as a Function of Atomic Layer Deposition Coating. Nanotoxicology 2017 11(3):313-326
7. Hussain S, Ji Z, Taylor AJ, Miller-DeGraff L, George M, Tucker J, Chang CH, Li R, Bonner JC, Garantziotis S. Multi- walled Carbon Nanotube Functionalization with High Molecular Weight Hyaluronan Significantly Reduces Pulmonary Injury. ACS Nano 2016. 10(8):7675-88.
8. Hussain S, Kodavanti PP, Marshburn JD, Janoshazi A, Marinakos SM, George M, Rice A, Wiesner MR and Garantziotis S. Decreased Uptake and Enhanced Mitochondrial Protection Underlie Reduced Toxicity of Nanoceria in Human Macrophages Compared to Monocytes. 2016. J. Biomed. Nanotechnol. 2016. 12, 2139– 2150
9. Kolinsky DJ,..,Hussain S,.., Zughaier SM, Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Autophagy 2016;12(1):1-222.
10. Guadagnini R, Moreau K, Hussain S, Marano F, Boland S. Interaction of nanoparticles used in medical applications with lung epithelial cells: cytotoxicity, oxidative stress and inflammatory response. Nanotoxicology 2015, 9 S1:25-32.
11. Hussain S, Sangtian S, Anderson SM, Snyder RJ, Marshburn JD, Rice AB, Bonner J, Garantziotis S. Inflammasome Activation in Airway Epithelial Cells after Multi-Walled Carbon Nanotube Exposure Mediates a Profibrotic Response in Lung Fibroblasts. Part Fibre Toxicol. 2014, 11:28.
12. Hussain S, Garantziotis S, Rodrigues-Lima F, Dupret JM, Baeza-Squiban A, Boland S. Intracellular signal modulation by nanomaterials. A, Adv Exp Med Biol. 811:111-34.
13. Snyder R, Hussain S, Rice A, Garantziotis S. Multi-Walled Carbon Nanotubes Induce Altered Morphology and Loss of Barrier Function in Human Bronchial Epithelia at Non-Cytotoxic Doses. Int. J. Nanomedicine 2014, 9:4093-105.
14. Boland S, Hussain S, Baeza-Squiban A, "Carbon Black and Titanium Dioxide Nanoparticles Induce Distinct Molecular Mechanisms of Toxicity" Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014, 6(6):641-52.
15. Yokel RA, Hussain S, Garantziotis S, Demokritou P, Castranova V and Cassee F. The Yin: An adverse health perspective of nanoceria: uptake, distribution, accumulation, and the mechanisms of its toxicity. Environ. Sci.: Nano 2014, 1(5):406-428.
16. Taylor AJ, McClure C, Shipley-Philips JK, Thompson EA, Hussain S, Garantziotis S, Parsons GN, Bonner JC. Atomic Layer Deposition Coating of Carbon Nanotubes with Aluminum Oxide Alters Pro-Fibrogenic Cytokine Expression by Human Mononuclear Phagocytes In vitro and Reduces Lung Fibrosis in Mice In vivo PLOS One 2014. 9(9):e106870.
17. Hussain S and Garantziotis S. Interplay between apoptotic and autophagy pathways after exposure to cerium dioxide nanoparticles in human monocytes. Autophagy. 2013. 9(1):101-103.
18. Hussain S, Vanoirbeek J, Boland S, Haenen S, Marano F, Nemery B, Hoet PHM. Local lung inflammation leads to targeting of distinct organs by gold nanoparticles. BioMed Res Int (formerly Journal of Biomedicine and Biotechnology) 2013:923475.
19. Hussain S, Al-Nsour F, Rice A, Marshburn J, Ji Z, Zink I, Walker N, Garantziotis S. Cerium dioxide nanoparticles induce cell death in human peripheral blood monocytes through apoptosis and autophagy. ACS Nano. 2012. 6(7):5820-5829.
20. Hussain S, Vanoirbeek J, Boland S, Marano F, Nemery B, Hoet PHM. Nanoparticles modulate in vivo chemical sensitization. Part Fibre Toxicol. 2012. 9:15
21. Hussain S, Al-Nsour F, Rice AB, Marshburn J, Ji Z, Zink JI, Yingling B, Walker NJ, Garantziotis S. Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response of human monocytes. Int. J. Nanomedicine 2012. 2; 7:1387-97.
22. Hussain S, Vanoirbeek J, Hoet P. Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012. 4(2):169-83.
23. Hussain S, Jeroen JAJ, Luyts K, De Vooght V, Verbeken E, Boland S, Marano F, Nemery B, Hoet PHM. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model of asthma. Eur Respir J. 2011. 37(2):299-309.
24. Sanfins E, Dairou J, Hussain S, Busi F, Chaffotte A, Rodrigues-Lima F and Dupret JM. Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymes ACS Nano. 2011. 5(6) :4504-4511.
25. Marano F, Hussain S, Rodrigues-Lima F, Baeza-Squiban A and Boland S. Nanoparticles: molecular targets and cell signaling. Arch Toxicol 2011. 85:733–741.
26. Boland S, Guadagnini R, Baeza-Squiban A, Hussain S, Marano F. Nanoparticles used in medical applications for the lung: hopes for nanomedicine and fears for nanotoxicity. J. Phys.: Conf. Ser. 2011. 304: 012031.
27. Hussain S, Thomson CJL, Ferecatu I, Borot C, Andreau K, Martens JA, Fleury J, Baeza-Squiban A, Marano F and Boland S. Carbon Black and Titanium Dioxide Nanoparticles Elicit Distinct Apoptotic Pathways in Bronchial Epithelial Cells. Part Fibre Toxicol. 2010. 7:10.
28. Val S, Hussain S*, Boland S, Hamel R, Baeza-Squiban A, Marano F. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol. 2009. 21: Sl 1:115-22. *Equal contribution first authors
29. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LCJ, Martens JA, Billon-Galland MA, Fleury-Feith J, Moisan F, Pairon JC, Marano F. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: Role of particle surface area and internalized amount. Toxicology 2009. 260, 142–149.
30. Hussain S, Khan MZ, Khan A, Javed I, Asi MR. Toxico-pathological effects in rats induced by concurrent exposure to aflatoxin and cypermethrin. Toxicon 2009. 53, 33–41.
31. Hussain S, I. Ali, A. Khan. Hematological and Plasma Proteins Findings in Fayoumi Hen Suffering from ascites. Vet. J. 2004. 24(4), 203-204.
The Hussain Lab is a “Translation Nanotoxicology and Environmental Health Laboratory.” We study pulmonary and systemic health impacts of inhalation exposures/co-exposures to environmentally relevant particulates (Particulate Matter, Engineered Nanomaterials) and gases (O3, NOx etc.,). Areas of interest currently under investigation are
1) Inflammation, injury and repair of lungs in response to environmental insults
2) Lung and gut microbial dysbiosis after environmental exposures
3) Gene x Environment interaction in environmental lung injury
4) Systemic outcomes after gestational inhalation exposures
We utilize state of the art Pulmonary Function Measurements, Air-Liquid Interface Cultures, 3-D Organoids and disease animal models (genetic and acquired susceptibility) to elaborate organismal/cellular responses and mechanistic pathways after environmental exposures.
More details about Dr. Hussain’s research program can be found at https://hussainlab.org/
Inhalation Exposures (particles, ozone etc)
Disease Animal Models (Asthma, Fibrosis, COPD, Contact Sensitivity)
Airway Physiology Measurements (Flexivent System)
Primary Cell Cultures (Human and Rodent)
3-D Airway Epithelial Cell Models (Human and Rodent)
Isolation, Culture and Study of Various Cell Types from Lungs, Blood and Bone Marrow
Transgenic, floxed and conditionally KO mouse models
Grants and Research
R01 ES031253 Impact of Particle and Ozone Inhalation Co-Exposure on Alveolar Epithelial RegenerationNIH/NIEHS Outstanding New Environmental Scientist (ONES), Career Development Award
Role: Principal Investigator
An association of NOD-like receptor (NLR) expression and single nucleotide polymorphism with susceptibility and severity of COVID-19
U54 GM104942 (Hodder)
Role: Principal Investigator - Pilot Project
Faculty Startup Funding, West Virginia University School of Medicine
PI: Salik Hussain, PhD
Postdoctoral Fellow - Physiology and Pharmacology (14910)
The Department of Physiology and Pharmacology in the West Virginia University School of Medicine is seeking applications for a Postdoctoral Fellow. This position is responsible for a translational project to elucidate the role of environmental exposures and innate immune signaling in lung injury and repair. Current research is focused on the understanding of molecular and cellular basis of pulmonary disease susceptibility after inhalation exposures to environmental stressors (xenobiotic particles and gases).
PhD in toxicology, cell and molecular biology, immunology, developmental biology, regenerative medicine, or a relevant biomedical field is required. One to two years of hands on experience in animal models of pulmonary diseases and/or cell culture techniques is required. This experience is typically acquired through the course of doctoral training.
Please submit 1) cover letter 2) current CV 3) three references (contact information). To apply online https://wvu.taleo.net/careersection/staff/jobdetail.ftl?job=14910&tz=GMT-04%3A00&tzname=America%2FNew_York
West Virginia University is an Equal Opportunity Employer and is the recipient of an NSF ADVANCE award for gender equity. The University values diversity among its faculty, staff, and students, and invites applications from all qualified applicants regardless of race, ethnicity, color, religion, gender identity, sexual orientation, age, nationality, genetics, disability, or veteran status.